Anixa Biosciences (ANIX) Metrics: History & Chart

Anixa Biosciences, Inc.(ANIX)

Biotechnology · San Jose, CA

$2.950.00 (0.00%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

About Anixa Biosciences, Inc.

Anixa Biosciences, Inc. (ANIX) is a biotechnology company dedicated to pioneering therapies and vaccines. Its core mission revolves around addressing critical, unmet medical needs, particularly within the fields of oncology (cancer) and infectious diseases. Among its therapeutic pipeline, Anixa is developing a novel chimeric endocrine receptor T-cell (CER-T) technology, an innovative adaptation of CAR-T, specifically for ovarian cancer treatment. The company is also engaged in the discovery and development of antiviral drug candidates to combat COVID-19, focusing on the inhibition of specific viral protein functions. On the vaccine front, Anixa's initiatives include a vaccine designed to target triple-negative breast cancer and a distinct preventative vaccine aimed at ovarian cancer. Beyond specific therapies and vaccines, Anixa also has immuno-therapy drugs for various cancers in its development portfolio. A key collaboration exists with MolGenie GmbH for the discovery and development of its COVID-19 antiviral candidates. Tracing its origins back to an incorporation in 1982, the company initially operated as ITUS Corporation before adopting the name Anixa Biosciences, Inc. in October 2018. It is headquartered in San Jose, California.

San Jose, CA

4 employees

www.anixa.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Amit Kumar

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	+5.73%
30D Total Return	-3.91%
YTD Total Return	-5.45%
1Y Total Return	-9.79%
3Y Total Return	-18.94%
5Y Total Return	-35.01%
10Y Total Return	-37.88%
15Y Total Return	-26.26%
20Y Total Return	-79.99%

2026	-5.45%
2025	+34.48%
2024	-40.21%
2023	-8.71%
2022	+43.10%
2021	-3.26%
2020

CAGR TTM	-9.74%
CAGR 3Y	-6.76%
CAGR 5Y	-8.26%
CAGR 10Y	-4.65%
CAGR 15Y	-2.01%
CAGR 20Y	-7.73%

PE Ratio	70.22
PE Ratio Avg TTM	597.78
PE Ratio Avg 3Y	597.78
Current VS TTM Avg	-88.25%
Current VS 3Y Avg	-88.25%
Current VS 5Y Avg	-88.25%

All Metrics

ANIX Valuation Metrics

ANIX Stock Price Metrics

ANIX Dividend Metrics

ANIX Growth Rate Metrics

ANIX Discounted Cash Flow Metrics

ANIX Returns By Period

ANIX Yearly Returns

ANIX Average Annual Returns By Period (CAGR)

ANIX Revenue Metrics

ANIX PE Ratio Metrics

ANIX PS Ratio Metrics

ANIX PB Ratio Metrics

ANIX Price to Free Cash Flow Ratio Metrics

ANIX Debt to Equity Ratio Metrics

ANIX PEG Ratio Metrics

ANIX FCF Yield

ANIX Earnings Yield

ANIX EBITDA Yield

ANIX OCF Yield

ANIX EV/EBIT Ratio Metrics

ANIX EV/EBITDA Ratio Metrics

ANIX EV/Assets Ratio Metrics

ANIX EV/Sales Ratio Metrics

ANIX Current Ratio Metrics

ANIX Quick Ratio Metrics

ANIX ROIC Metrics

ANIX Return on Assets Metrics

ANIX Return on Equity Metrics

ANIX Net Profit Margin Metrics

ANIX Gross Profit Margin Metrics

ANIX Tax Rate Metrics

PS Ratio	381.84
PS Ratio Avg TTM	506.20
PS Ratio Avg 3Y	387.29
Current VS TTM Avg	-24.57%
Current VS 3Y Avg	-1.41%
Current VS 5Y Avg	+20.58%

PB Ratio	6.97
PB Ratio Avg TTM	7.02
PB Ratio Avg 3Y	5.50
Current VS TTM Avg	-0.76%
Current VS 3Y Avg	+26.81%
Current VS 5Y Avg	+45.40%

PFCF Ratio	21.40
PFCF Ratio Avg TTM	17.97
PFCF Ratio Avg 3Y	17.97
Current VS TTM Avg	+19.07%
Current VS 3Y Avg	+19.07%
Current VS 5Y Avg	+19.07%

Debt/Equity Ratio	0.01
Debt/Equity Ratio Avg TTM	0.01
Debt/Equity Ratio Avg 3Y	0.01
Current VS TTM Avg	-5.81%
Current VS 3Y Avg	+11.36%
Current VS 5Y Avg	+31.09%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	4.67%
FCF Yield Avg TTM	5.62%
FCF Yield Avg 3Y	5.62%
Current VS TTM Avg	-16.87%
Current VS 3Y Avg	-16.87%
Current VS 5Y Avg	-16.87%

Earnings Yield	1.42%
Earnings Yield Avg TTM	0.56%
Earnings Yield Avg 3Y	0.56%
Current VS TTM Avg	+152.42%
Current VS 3Y Avg	+152.42%
Current VS 5Y Avg	+152.42%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	32.45
Ev/Ebit Ratio Avg TTM	28.81
Ev/Ebit Ratio Avg 3Y	28.81
Current VS TTM Avg	+12.63%
Current VS 3Y Avg	+12.63%
Current VS 5Y Avg	+12.63%

Ev/Ebitda Ratio	109.16
Ev/Ebitda Ratio Avg TTM	65.13
Ev/Ebitda Ratio Avg 3Y	65.13
Current VS TTM Avg	+67.61%
Current VS 3Y Avg	+67.61%
Current VS 5Y Avg	+67.61%

Ev/Assets Ratio	6.61
Ev/Assets Ratio Avg TTM	6.68
Ev/Assets Ratio Avg 3Y	5.20
Current VS TTM Avg	-1.00%
Current VS 3Y Avg	+27.21%
Current VS 5Y Avg	+52.11%

Ev/Sales Ratio	377.86
Ev/Sales Ratio Avg TTM	487.04
Ev/Sales Ratio Avg 3Y	356.48
Current VS TTM Avg	-22.42%
Current VS 3Y Avg	+6.00%
Current VS 5Y Avg	+29.08%

Current Ratio	8.54
Current Ratio Avg TTM	9.41
Current Ratio Avg 3Y	10.88
Current VS TTM Avg	-9.16%
Current VS 3Y Avg	-21.46%
Current VS 5Y Avg	-44.77%

Quick Ratio	8.54
Quick Ratio Avg TTM	9.41
Quick Ratio Avg 3Y	10.88
Current VS TTM Avg	-9.16%
Current VS 3Y Avg	-21.46%
Current VS 5Y Avg	-44.78%

ROIC	(82.35%)
ROIC Avg 3Y	(70.02%)
ROIC Avg 5Y	(59.97%)
Current VS 3Y Avg	-17.61%
Current VS 5Y Avg	-37.30%
Current VS 10Y Avg	-2.73%

ROA	(69.14%)
ROA Avg TTM	(16.17%)
ROA Avg 3Y	(14.47%)
Current VS TTM Avg	-327.46%
Current VS 3Y Avg	-377.90%
Current VS 5Y Avg	-440.03%

ROE	(72.02%)
ROE Avg TTM	(69.81%)
ROE Avg 3Y	(60.87%)
Current VS TTM Avg	-3.17%
Current VS 3Y Avg	-18.32%
Current VS 5Y Avg	-34.38%

Net Profit Margin	0.00%
Net Profit Margin Avg TTM	0.00%
Net Profit Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Gross Profit Margin	0.00%
Gross Pft Margin Avg TTM	0.00%
Gross Pft Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Tax Rate	0.00%
Tax Rate Avg 3Y	0.00%
Tax Rate Avg 5Y	0.00%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A